SS Innovations International, Inc. (NASDAQ: SSII) has been named Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing finalists including Intuitive Surgical (NASDAQ: ISRG), Johnson & Johnson (NYSE: JNJ), and Medtronic (NYSE: MDT). The award recognizes a single company demonstrating excellence in innovation, commercial success, industry leadership, and positive societal impact.
SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
This recognition positions SS Innovations as a leading player in the surgical robotics market, traditionally dominated by Intuitive Surgical's da Vinci system. The award underscores the company's potential to disrupt the market with more affordable alternatives. For more information on SS Innovations, visit the company's newsroom at https://ibn.fm/SSII.
The Surgical Robotics Industry Awards highlight the growing importance of robotic surgery in healthcare, with implications for improved patient outcomes, reduced recovery times, and lower healthcare costs. SS Innovations' win signals a shift towards cost-effective solutions that can democratize access to advanced surgical technologies globally.
